More
    Guided Solutions - Connecting Talent With Innovation/div>

    Virtual Incision Raises $46 Million in Series C Funding Round

    Surgical robotics innovator, Virtual Incision Corporation, has secured $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird...

    AI-assisted biotech startup Owkin becomes latest French unicorn

    French artificial intelligence (AI) and precision medicine startup Owkin startup has achieved unicorn status, after scoring a $180 million (€135M) investment from pharma firm...

    Digital mental health firm ieso lands $53M in Series B round

    Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US. UK digital mental healthcare firm ieso, today...

    Neuroplast secures €10 million in funding to boost clinical development of stem cell therapy for traumatic spinal cord injuries

    Neuroplast has raised a total of €10 million in a Series B funding round, the money of which will be used to obtain conditional...

    Cala Health scores $77M to expand its tremor-fighting wearable to new conditions

    After showing its wrist-worn bioelectronic device could help people reduce hand tremors, Cala Health has raised $77 million to help expand its technology to...

    Neurotech startup Beacon Biosignals scores $27M to bring AI to EEG analysis

    Beacon Biosignals technology analyzes EEGs to find insights brain activity. The company will use its new Series A financing to build alliances with more...

    AppliedVR raises $36M, pursues FDA clearance of first digital therapeutic

    The company is developing a digital therapeutic using VR to manage chronic lower back pain. It recently submitted an application for de novo clearance...

    Flywheel Closes $27.5 Million Series C Funding Round, Including Investment from Intuitive Ventures

    Leading cloud-based data management platform for biomedical research and collaboration, Flywheel, has announced the closure of its Series C funding round including an investment from Intuitive...

    Alcon scopes out $475M acquisition of glaucoma stent maker Ivantis

    Three years after Alcon pulled its CyPass Micro-Stent from the market due to safety concerns, the Novartis spinoff has found another glaucoma treatment device...

    Latest articles